Sightsavers awarded grant to fight neglected tropical diseases in Guinea-Bissau
The Astellas Global Health Foundation has awarded Sightsavers a grant of US$536,700 to help treat four neglected tropical diseases in Guinea-Bissau.
The grant will enable Sightsavers to distribute one million treatments to combat river blindness, lymphatic filariasis, schistosomiasis and intestinal worms in six endemic areas of the country.
More than 1.2 million people are at risk of infection in Guinea-Bissau and the treatments will help reduce the morbidity, mortality and disability associated with the debilitating diseases. Once they’re protected through medication, children can continue their education and adults can earn a living and support their families.
The Astellas Global Health Foundation is an international philanthropic organisation that focuses on improving access to health care, building community resilience and providing disaster support around the world. Sightsavers is one of five organisations that will benefit from the foundation’s latest grants, which will total US$3.9 million.
Read all our latest news stories
News from Sightsavers
Sightsavers to exhibit at UK’s largest optical event
Sightsavers is at the 100% Optical conference in London on 24-26 February, to raise awareness about avoidable blindness and invite eye health professionals to help protect sight worldwide.
Sightsavers awarded grant to help eliminate trachoma in Zambia
The Leona M. and Harry B. Helmsley Charitable Trust has awarded Sightsavers a grant of US$2.19 million to help fight the disease.
What we achieved in 2023
Sightsavers did incredible things during the year, but we couldn’t have done it without your help. Learn about our achievements, all made possible by you.
Inspirational stories direct to your inbox
Inspirational stories direct to your inbox
Want to hear more from Sightsavers? Join more than 170,000 supporters who receive inspiring emails about life-changing projects and ways to support our work.
You can unsubscribe at any time by clicking the link in each email, or by contacting our Supporter Care team via [email protected]
For more information see our privacy policy
